Breaking News Instant updates and real-time market news.

SENS

Senseonics

$0.51 /

+0.0332 (+6.98%)

13:46
07/29/20
07/29
13:46
07/29/20
13:46

Independence BCBS adds coverage for Senseonics' Eversense

In a policy bulletin dated July 28, Independence Blue Cross Blue Shield noted that its policy was updated to expand coverage for long-term interstitial continuous glucose monitoring systems for individuals with type 2 diabetes mellitus on an intensive insulin regimen defined as requiring three or more insulin injections per day, or utilizes an insulin pump. In addition, coverage was added for the implantation of an FDA-approved implantable glucose CGM system, for example Senseonics' Eversense, "when criteria for long-term interstitial CGMS is met," the policy bulletin states. Reference Link

SENS Senseonics
$0.51 /

+0.0332 (+6.98%)

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord

TODAY'S FREE FLY STORIES

Initiation
McEwen Mining transferred with a Buy at Alliance Global Partners » 07:05
09/29/20
09/29
07:05
09/29/20
07:05
MUX

McEwen Mining

/

+

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MUX McEwen Mining
/

+

MUX McEwen Mining
/

+

09/14/20 Roth Capital
McEwen Mining resumed with a Buy at Roth Capital
MUX McEwen Mining
/

+

  • 20
    Nov
MUX McEwen Mining
/

+

MUX McEwen Mining
/

+

Initiation
Cambridge Bancorp initiated with an Outperform at Raymond James » 07:04
09/29/20
09/29
07:04
09/29/20
07:04
CATC

Cambridge Bancorp

$50.63 /

+2.29 (+4.74%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CATC Cambridge Bancorp
$50.63 /

+2.29 (+4.74%)

CATC Cambridge Bancorp
$50.63 /

+2.29 (+4.74%)

08/27/20 DA Davidson
Cambridge Bancorp initiated with a Neutral at DA Davidson
08/17/20 Piper Sandler
Cambridge Bancorp upgraded to Overweight from Neutral at Piper Sandler
01/22/20 Piper Sandler
Cambridge Bancorp downgraded to Neutral from Overweight at Piper Sandler
12/11/19
Fly Intel: Top five analyst upgrades
CATC Cambridge Bancorp
$50.63 /

+2.29 (+4.74%)

  • 06
    Dec
Recommendations
Ligand price target raised to $195 from $190 at Roth Capital » 07:04
09/29/20
09/29
07:04
09/29/20
07:04
LGND

Ligand

$95.75 /

-1.56 (-1.60%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGND Ligand
$95.75 /

-1.56 (-1.60%)

LGND Ligand
$95.75 /

-1.56 (-1.60%)

09/23/20 H.C. Wainwright
H.C. Wainwright reiterates $229 target on Ligand after Captisol boost
08/14/20 Cantor Fitzgerald
Pfenex downgraded to Neutral from Overweight at Cantor Fitzgerald
08/11/20 H.C. Wainwright
Pfenex acquisition fits well with Ligand growing portfolio, says H.C. Wainwright
08/11/20 JMP Securities
Pfenex cut to Market Perform at JMP Securities on Ligand acquisition
LGND Ligand
$95.75 /

-1.56 (-1.60%)

LGND Ligand
$95.75 /

-1.56 (-1.60%)

Hot Stocks
Target announces Target Deal Days on October 13, 14 » 07:04
09/29/20
09/29
07:04
09/29/20
07:04
TGT

Target

$156.35 /

+1.95 (+1.26%)

Target announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGT Target
$156.35 /

+1.95 (+1.26%)

TGT Target
$156.35 /

+1.95 (+1.26%)

09/22/20 Cleveland Research
Target sales appear to be re-accelerating, says Cleveland Research
08/20/20 MKM Partners
Target facing 'likely deceleration' from August levels, says MKM Partners
08/20/20 JPMorgan
Target price target raised to $169 from $154 at JPMorgan
08/20/20 DA Davidson
Target price target raised to $179 from $152 at DA Davidson
TGT Target
$156.35 /

+1.95 (+1.26%)

TGT Target
$156.35 /

+1.95 (+1.26%)

TGT Target
$156.35 /

+1.95 (+1.26%)

TGT Target
$156.35 /

+1.95 (+1.26%)

Recommendations
Devon Energy combination with WPX makes sense, says Susquehanna » 07:04
09/29/20
09/29
07:04
09/29/20
07:04
DVN

Devon Energy

$9.80 /

+0.985 (+11.18%)

, WPX

WPX Energy

$5.18 /

+0.735 (+16.54%)

Susquehanna analyst Biju…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DVN Devon Energy
$9.80 /

+0.985 (+11.18%)

WPX WPX Energy
$5.18 /

+0.735 (+16.54%)

DVN Devon Energy
$9.80 /

+0.985 (+11.18%)

09/24/20 Scotiabank
Scotiabank adds EU super majors to coverage, shakes up oil ratings
09/14/20 Northland
Devon Energy initiated with an Outperform at Northland
08/26/20 Capital One
Devon Energy upgraded on robust FCF profile at Capital One
08/26/20 Capital One
Devon Energy upgraded to Overweight from Equalweight at Capital One
WPX WPX Energy
$5.18 /

+0.735 (+16.54%)

06:32 Today Citi
Citi adds Dropbox, removes WPX from 'Value Creators' list
05:38 Today MKM Partners
WPX Energy downgraded to Neutral from Buy at MKM Partners
09/22/20 Truist
WPX Energy upgraded to Buy from Hold at Truist
09/22/20 Truist
WPX Energy upgraded to Buy from Hold at Truist
DVN Devon Energy
$9.80 /

+0.985 (+11.18%)

WPX WPX Energy
$5.18 /

+0.735 (+16.54%)

DVN Devon Energy
$9.80 /

+0.985 (+11.18%)

WPX WPX Energy
$5.18 /

+0.735 (+16.54%)

DVN Devon Energy
$9.80 /

+0.985 (+11.18%)

WPX WPX Energy
$5.18 /

+0.735 (+16.54%)

DVN Devon Energy
$9.80 /

+0.985 (+11.18%)

WPX WPX Energy
$5.18 /

+0.735 (+16.54%)

Earnings
AngioDynamics reports Q1 adj. EPS 2c, consensus (7c) » 07:04
09/29/20
09/29
07:04
09/29/20
07:04
ANGO

AngioDynamics

$10.65 /

+0.58 (+5.76%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANGO AngioDynamics
$10.65 /

+0.58 (+5.76%)

ANGO AngioDynamics
$10.65 /

+0.58 (+5.76%)

04/08/20
Fly Intel: Top five analyst downgrades
04/08/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
04/07/20 KeyBanc
AngioDynamics downgraded to Sector Weight from Overweight at KeyBanc
12/30/19 Stifel
Avanos makes 'welcome addition' with 'highly experienced' CFO, says Stifel
ANGO AngioDynamics
$10.65 /

+0.58 (+5.76%)

ANGO AngioDynamics
$10.65 /

+0.58 (+5.76%)

Upgrade
Oneok upgraded to Buy from Neutral at UBS » 07:03
09/29/20
09/29
07:03
09/29/20
07:03
OKE

Oneok

$26.00 /

+0.98 (+3.92%)

UBS analyst Shneur…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OKE Oneok
$26.00 /

+0.98 (+3.92%)

OKE Oneok
$26.00 /

+0.98 (+3.92%)

09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Scotiabank
Oneok downgraded to Sector Perform with $31 target at Scotiabank
09/21/20 Scotiabank
Oneok downgraded to Sector Perform from Outperform at Scotiabank
08/28/20 Seaport Global
Seaport Global upgrades Oneok to Buy on better second half visibility
OKE Oneok
$26.00 /

+0.98 (+3.92%)

  • 12
    Jun
OKE Oneok
$26.00 /

+0.98 (+3.92%)

OKE Oneok
$26.00 /

+0.98 (+3.92%)

Initiation
Live Oak Bancshares initiated with an Outperform at Raymond James » 07:03
09/29/20
09/29
07:03
09/29/20
07:03
LOB

Live Oak Bancshares

$24.99 /

+1.2 (+5.04%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOB Live Oak Bancshares
$24.99 /

+1.2 (+5.04%)

LOB Live Oak Bancshares
$24.99 /

+1.2 (+5.04%)

09/10/20 Truist
Live Oak Bancshares price target raised to $28 from $23 at Truist
09/09/20 Piper Sandler
Live Oak Bancshares assumed with a Neutral at Piper Sandler
05/12/20 Itau BBA
Live Oak Bancshares downgraded to Market Perform from Outperform at Itau BBA
12/05/19 SunTrust
Live Oak Bancshares upgraded to Buy from Hold at SunTrust
LOB Live Oak Bancshares
$24.99 /

+1.2 (+5.04%)

Earnings
Big Lots sees Q3 EPS 50c-70c, consensus 21c » 07:03
09/29/20
09/29
07:03
09/29/20
07:03
BIG

Big Lots

$47.73 /

+1.25 (+2.69%)

Big Lots provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIG Big Lots
$47.73 /

+1.25 (+2.69%)

BIG Big Lots
$47.73 /

+1.25 (+2.69%)

08/31/20 Loop Capital
Big Lots price target raised to $60 from $55 at Loop Capital
08/31/20 Deutsche Bank
Big Lots price target raised to $52 from $42 at Deutsche Bank
08/31/20 Barclays
Big Lots price target raised to $50 from $34 at Barclays
06/29/20
Fly Intel: Top five analyst upgrades
BIG Big Lots
$47.73 /

+1.25 (+2.69%)

BIG Big Lots
$47.73 /

+1.25 (+2.69%)

BIG Big Lots
$47.73 /

+1.25 (+2.69%)

BIG Big Lots
$47.73 /

+1.25 (+2.69%)

Hot Stocks
Universal Health announces information technology security incident » 07:03
09/29/20
09/29
07:03
09/29/20
07:03
UHS

Universal Health

$104.29 /

-1.07 (-1.02%)

Universal Health Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UHS Universal Health
$104.29 /

-1.07 (-1.02%)

UHS Universal Health
$104.29 /

-1.07 (-1.02%)

09/21/20 JPMorgan
JPMorgan downgrades Universal Health to Underweight on stalled recovery
09/21/20 JPMorgan
Universal Health downgraded to Underweight from Neutral at JPMorgan
06/09/20 Barclays
Barclays upgrades Universal Health on higher mental health demand
06/09/20 Barclays
Universal Health upgraded to Overweight from Equal Weight at Barclays
UHS Universal Health
$104.29 /

-1.07 (-1.02%)

UHS Universal Health
$104.29 /

-1.07 (-1.02%)

UHS Universal Health
$104.29 /

-1.07 (-1.02%)

UHS Universal Health
$104.29 /

-1.07 (-1.02%)

Hot Stocks
Immatics appoints Arnd Christ as CFO » 07:02
09/29/20
09/29
07:02
09/29/20
07:02
IMTX

Immatics

$9.81 /

-0.33 (-3.25%)

, IFRX

InflaRx

$4.30 /

-0.195 (-4.34%)

Immatics (IMTX) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMTX Immatics
$9.81 /

-0.33 (-3.25%)

IFRX InflaRx
$4.30 /

-0.195 (-4.34%)

IMTX Immatics
$9.81 /

-0.33 (-3.25%)

09/21/20 Goldman Sachs
Immatics initiated with a Buy at Goldman Sachs
07/27/20
Fly Intel: Top five analyst initiations
07/27/20 SVB Leerink
SVB Leerink bullish on Immatics, initiates with an Outperform
07/27/20 SVB Leerink
Immatics initiated with an Outperform at SVB Leerink
IFRX InflaRx
$4.30 /

-0.195 (-4.34%)

06/17/20 Raymond James
Raymond James says market wrong on InflaRx COVID-19 data
06/17/20 Raymond James
Market wrong on InflaRx COVID-19 data, says Raymond James
06/16/20 BTIG
InflaRx initiated with a Buy at BTIG
05/21/20 BMO Capital
InflaRx price target raised to $7 from $4 at BMO Capital
IMTX Immatics
$9.81 /

-0.33 (-3.25%)

IFRX InflaRx
$4.30 /

-0.195 (-4.34%)

IFRX InflaRx
$4.30 /

-0.195 (-4.34%)

IFRX InflaRx
$4.30 /

-0.195 (-4.34%)

Hot Stocks
Acceleron, Bristol-Myers announce Health Canada approval of REBLOZYL » 07:01
09/29/20
09/29
07:01
09/29/20
07:01
XLRN

Acceleron

$108.76 /

+0.54 (+0.50%)

, BMY

Bristol-Myers

$59.72 /

+0.22 (+0.37%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$108.76 /

+0.54 (+0.50%)

BMY Bristol-Myers
$59.72 /

+0.22 (+0.37%)

XLRN Acceleron
$108.76 /

+0.54 (+0.50%)

08/24/20 Raymond James
Acceleron still 'meaningfully undervalued,' says Raymond James
08/24/20 Raymond James
Acceleron initiated with a Strong Buy at Raymond James
08/06/20 Piper Sandler
Acceleron's Reblozyl off to very strong start, says Piper Sandler
07/07/20 Piper Sandler
Acceleron price target lowered to $130 from $135 at Piper Sandler
BMY Bristol-Myers
$59.72 /

+0.22 (+0.37%)

05:26 Today Berenberg
Bristol-Myers initiated with a Buy at Berenberg
09/22/20 Oppenheimer
Bluebird Bio review timeline consistent with expectations, says Oppenheimer
08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
XLRN Acceleron
$108.76 /

+0.54 (+0.50%)

BMY Bristol-Myers
$59.72 /

+0.22 (+0.37%)

  • 01
    Jul
BMY Bristol-Myers
$59.72 /

+0.22 (+0.37%)

XLRN Acceleron
$108.76 /

+0.54 (+0.50%)

BMY Bristol-Myers
$59.72 /

+0.22 (+0.37%)

BMY Bristol-Myers
$59.72 /

+0.22 (+0.37%)

Hot Stocks
GFL Environmental receives DOJ approval for WCA Waste acquisition » 06:59
09/29/20
09/29
06:59
09/29/20
06:59
GFL

GFL Environmental

$21.08 /

+0.56 (+2.73%)

GFL Environmental…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GFL GFL Environmental
$21.08 /

+0.56 (+2.73%)

GFL GFL Environmental
$21.08 /

+0.56 (+2.73%)

09/02/20 Stifel
Stifel says short report 'woefully misrepresented' GFL Environmental accounting
08/18/20 Goldman Sachs
GFL Environmental upgraded to Buy from Neutral at Goldman Sachs
08/18/20 Stifel
GFL Environmental selloff on short report a buying opportunity, says Stifel
08/14/20 TD Securities
GFL Environmental price target raised to C$32 from C$29 at TD Securities
  • 03
    Mar
GFL GFL Environmental
$21.08 /

+0.56 (+2.73%)

GFL GFL Environmental
$21.08 /

+0.56 (+2.73%)

Hot Stocks
LabCorp and Infirmary announce collaboration » 06:59
09/29/20
09/29
06:59
09/29/20
06:59
LH

LabCorp

$183.94 /

+3.02 (+1.67%)

LabCorp and Infirmary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LH LabCorp
$183.94 /

+3.02 (+1.67%)

LH LabCorp
$183.94 /

+3.02 (+1.67%)

08/28/20 Mizuho
Quest, LabCorp weakness yesterday should be bought, says Mizuho
07/31/20 Mizuho
LabCorp price target raised to $215 from $186 at Mizuho
07/29/20 SunTrust
LabCorp price target raised to $240 from $220 at SunTrust
07/29/20 Deutsche Bank
LabCorp price target raised to $230 from $210 at Deutsche Bank
LH LabCorp
$183.94 /

+3.02 (+1.67%)

LH LabCorp
$183.94 /

+3.02 (+1.67%)

LH LabCorp
$183.94 /

+3.02 (+1.67%)

LH LabCorp
$183.94 /

+3.02 (+1.67%)

Hot Stocks
Sonic Automotive acquires four acres of land adjacent to EchoPark » 06:57
09/29/20
09/29
06:57
09/29/20
06:57
SAH

Sonic Automotive

$40.95 /

+2.09 (+5.38%)

Sonic Automotive…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAH Sonic Automotive
$40.95 /

+2.09 (+5.38%)

SAH Sonic Automotive
$40.95 /

+2.09 (+5.38%)

08/28/20 JPMorgan
Lithia Motors price target raised to $280 from $240 at JPMorgan
08/27/20 Benchmark
Benchmark sees more strong earnings from auto dealers, ups targets in group
07/08/20 JPMorgan
Sonic Automotive price target raised to $39 from $38 at JPMorgan
05/26/20 JPMorgan
Sonic Automotive price target raised to $29 from $25 at JPMorgan
SAH Sonic Automotive
$40.95 /

+2.09 (+5.38%)

Hot Stocks
Acasti Pharma announces review of strategic alternatives » 06:56
09/29/20
09/29
06:56
09/29/20
06:56
ACST

Acasti Pharma

$0.21 /

-0.0033 (-1.56%)

Acasti Pharma announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACST Acasti Pharma
$0.21 /

-0.0033 (-1.56%)

ACST Acasti Pharma
$0.21 /

-0.0033 (-1.56%)

09/02/20 Aegis
Acasti Pharma downgraded to Hold from Buy at Aegis
09/01/20
Fly Intel: Top five analyst downgrades
08/31/20 Oppenheimer
Acasti Pharma downgraded to Perform from Outperform at Oppenheimer
08/31/20 B. Riley FBR
Acasti Pharma downgraded to Neutral from Buy at B. Riley FBR
ACST Acasti Pharma
$0.21 /

-0.0033 (-1.56%)

Upgrade
PrairieSky Royalty upgraded to Outperform from Sector Perform at RBC Capital » 06:55
09/29/20
09/29
06:55
09/29/20
06:55
PREKF

PrairieSky Royalty

$0.00 /

+ (+0.00%)

RBC Capital analyst Luke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PREKF PrairieSky Royalty
$0.00 /

+ (+0.00%)

05:22 Today RBC Capital
PrairieSky Royalty upgraded to Outperform from Sector Perform at RBC Capital
09/11/20 Stifel
Stifel backs Buy on PrairieSky Royalty after share repurchase disclosure
07/22/20 Stifel
PrairieSky Royalty price target raised to C$11.50 from C$10.25 at Stifel
06/15/20 Scotiabank
PrairieSky Royalty price target lowered to C$13 from C$14 at Scotiabank
Recommendations
NIO may become next iconic auto brand, says Deutsche Bank » 06:54
09/29/20
09/29
06:54
09/29/20
06:54
NIO

NIO Inc.

$18.81 /

+0.5 (+2.73%)

, TSLA

Tesla

$420.96 /

+13.75 (+3.38%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO NIO Inc.
$18.81 /

+0.5 (+2.73%)

TSLA Tesla
$420.96 /

+13.75 (+3.38%)

NIO NIO Inc.
$18.81 /

+0.5 (+2.73%)

09/08/20 Deutsche Bank
Deutsche sees NIO co-existing with Tesla in China, starts with $24 target
09/08/20 Deutsche Bank
NIO Inc. initiated with a Buy at Deutsche Bank
09/03/20 Credit Suisse
NIO Inc. price target raised to Street-high $25 from $17.50 at Credit Suisse
08/28/20 Citi
NIO share issuance potentially earnings accretive, says Citi
TSLA Tesla
$420.96 /

+13.75 (+3.38%)

09/24/20 Roth Capital
Tesla's Battery Day event 'disappoints,' says Roth Capital
09/24/20 Daiwa
Daiwa upgrades Rockwell Automation after customer Tesla's Battery Day
09/24/20 Wedbush
Wedbush downgrades Nikola to sell on 'dark cloud,' Tesla innovations
09/23/20
Fly Intel: Top five analyst upgrades
NIO NIO Inc.
$18.81 /

+0.5 (+2.73%)

TSLA Tesla
$420.96 /

+13.75 (+3.38%)

  • 31
    Aug
  • 11
    Jun
  • 14
    Feb
NIO NIO Inc.
$18.81 /

+0.5 (+2.73%)

TSLA Tesla
$420.96 /

+13.75 (+3.38%)

NIO NIO Inc.
$18.81 /

+0.5 (+2.73%)

TSLA Tesla
$420.96 /

+13.75 (+3.38%)

NIO NIO Inc.
$18.81 /

+0.5 (+2.73%)

TSLA Tesla
$420.96 /

+13.75 (+3.38%)

Recommendations
RingCentral price target raised to $300 from $280 at Morgan Stanley » 06:53
09/29/20
09/29
06:53
09/29/20
06:53
RNG

RingCentral

$267.80 /

-1.66 (-0.62%)

, MSFT

Microsoft

$209.69 /

+1.94 (+0.93%)

, ZM

Zoom Video

$487.86 /

-8.635 (-1.74%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RNG RingCentral
$267.80 /

-1.66 (-0.62%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

RNG RingCentral
$267.80 /

-1.66 (-0.62%)

09/18/20 JPMorgan
RingCentral recent pullback a buying opportunity, says JPMorgan
08/04/20 Craig-Hallum
RingCentral price target raised to $340 from $330 at Craig-Hallum
08/04/20 Wells Fargo
RingCentral price target raised to $345 from $310 at Wells Fargo
08/04/20 Northland
RingCentral price target raised to $320 from $290 at Northland
MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

09/24/20 Lynx
Microsoft's Bethesda deal positive for AMD, says Lynx
09/24/20 Jefferies
Jefferies 'overwhelmed' by announcements and innovation at Microsoft Ignite
09/23/20 Colliers
Harmonic opportunity in focus after SES partners with Microsoft, says Colliers
09/23/20 Baird
Demand for PS5, Xbox Series X continues to look 'strong,' says Baird
ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

09/28/20 Morgan Stanley
Morgan Stanley leans 'more cautious' on Zoom with shares 'priced for perfection'
09/21/20 Summit Insights
Snowflake initiated with a Sell at Summit Insights
09/14/20 Baird
Zoom Video still in early innings of market penetration, says Baird
09/03/20 Needham
Crowdstrike price target raised to $170 from $120 at Needham
RNG RingCentral
$267.80 /

-1.66 (-0.62%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

  • 13
    Nov
RNG RingCentral
$267.80 /

-1.66 (-0.62%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

RNG RingCentral
$267.80 /

-1.66 (-0.62%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

RNG RingCentral
$267.80 /

-1.66 (-0.62%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

Hot Stocks
NiSource provides growth strategy update at virtual investor day » 06:50
09/29/20
09/29
06:50
09/29/20
06:50
NI

NiSource

$21.87 /

-0.28 (-1.26%)

NiSource has nearly $14B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NI NiSource
$21.87 /

-0.28 (-1.26%)

09/28/20 BMO Capital
NiSource price target lowered to $24 from $27 at BMO Capital
09/23/20 Jefferies
NiSource upgraded to Buy ahead of investor day at Jefferies
09/23/20 Jefferies
NiSource upgraded to Buy from Hold at Jefferies
04/30/20 BofA
NiSource downgraded to Neutral from Buy at BofA
NI NiSource
$21.87 /

-0.28 (-1.26%)

Recommendations
Maxar Technologies price target raised to $30 from $25 at RBC Capital » 06:50
09/29/20
09/29
06:50
09/29/20
06:50
MAXR

Maxar Technologies

$25.37 /

+1.16 (+4.79%)

RBC Capital analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAXR Maxar Technologies
$25.37 /

+1.16 (+4.79%)

MAXR Maxar Technologies
$25.37 /

+1.16 (+4.79%)

08/06/20 TD Securities
Maxar Technologies upgraded to Buy from Speculative Buy at TD Securities
06/24/20 JPMorgan
Maxar Technologies price target raised to $20 from $16 at JPMorgan
01/15/20 Credit Suisse
Maxar Technologies upgraded to Neutral from Underperform at Credit Suisse
01/08/20 JPMorgan
Maxar Technologies price target raised to $25 from $15 at JPMorgan
MAXR Maxar Technologies
$25.37 /

+1.16 (+4.79%)

MAXR Maxar Technologies
$25.37 /

+1.16 (+4.79%)

MAXR Maxar Technologies
$25.37 /

+1.16 (+4.79%)

Recommendations
Cleveland-Cliffs acquisition positive for company, industry, says Citi » 06:48
09/29/20
09/29
06:48
09/29/20
06:48
CLF

Cleveland-Cliffs

$6.56 /

+0.68 (+11.56%)

Citi analyst Alexander…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLF Cleveland-Cliffs
$6.56 /

+0.68 (+11.56%)

CLF Cleveland-Cliffs
$6.56 /

+0.68 (+11.56%)

09/14/20 B. Riley FBR
Cleveland-Cliffs a 'compelling contrarian opportunity,' says B. Riley FBR
07/31/20 GLJ Research
Cleveland-Cliffs downgraded to Sell from Hold at GLJ Research
06/03/20 GLJ Research
Cleveland-Cliffs upgraded to Hold from Sell at GLJ Research
04/15/20 Credit Suisse
Cleveland-Cliffs reinstated with a Neutral at Credit Suisse
CLF Cleveland-Cliffs
$6.56 /

+0.68 (+11.56%)

CLF Cleveland-Cliffs
$6.56 /

+0.68 (+11.56%)

CLF Cleveland-Cliffs
$6.56 /

+0.68 (+11.56%)

CLF Cleveland-Cliffs
$6.56 /

+0.68 (+11.56%)

Hot Stocks
Aptorum Group launches infectious disease liquid biopsy subsidiary » 06:47
09/29/20
09/29
06:47
09/29/20
06:47
APM

Aptorum Group

$1.17 /

-0.14 (-10.69%)

Aptorum Group Limited…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APM Aptorum Group
$1.17 /

-0.14 (-10.69%)

APM Aptorum Group
$1.17 /

-0.14 (-10.69%)

07/13/20 Alliance Global Partners
Aptorum Group initiated with a Buy at Alliance Global Partners
Hot Stocks
Annovis Bio announces publication of peer-reviewed data on Posiphen » 06:46
09/29/20
09/29
06:46
09/29/20
06:46
ANVS

Annovis Bio

$4.55 /

+0.055 (+1.22%)

Annovis Bio announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANVS Annovis Bio
$4.55 /

+0.055 (+1.22%)

ANVS Annovis Bio
$4.55 /

+0.055 (+1.22%)

06/18/20 Maxim
Annovis Bio initiated with a Buy at Maxim
  • 29
    Jan
ANVS Annovis Bio
$4.55 /

+0.055 (+1.22%)

Initiation
Magnite initiated with an Outperform at RBC Capital » 06:46
09/29/20
09/29
06:46
09/29/20
06:46
MGNI

Magnite

$6.67 /

+0.21 (+3.25%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGNI Magnite
$6.67 /

+0.21 (+3.25%)

MGNI Magnite
$6.67 /

+0.21 (+3.25%)

09/03/20
Fly Intel: Top five analyst initiations
09/03/20 Needham
Magnite initiated with a Buy at Needham
09/03/20 Needham
Magnite initiated with a Buy at Needham
08/13/20 Truist
Magnite price target raised to $9 from $7 at Truist
MGNI Magnite
$6.67 /

+0.21 (+3.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.